Dynavax to Present at the 7th Annual Evercore HealthCONx Conference
Dynavax Technologies (Nasdaq: DVAX), a commercial-stage biopharmaceutical company focused on innovative vaccine development, has announced its upcoming participation at the 7th Annual Evercore HealthCONx Conference. The presentation is scheduled for Tuesday, December 3 at 2:35 p.m. ET.
Interested parties can access the webcast through the 'Events & Presentations' section on the company's investor relations website at investors.dynavax.com/events-presentations.
Dynavax Technologies (Nasdaq: DVAX), un'azienda biofarmaceutica in fase commerciale focalizzata sullo sviluppo di vaccini innovativi, ha annunciato la sua prossima partecipazione alla 7ª Conferenza Annuale Evercore HealthCONx. La presentazione è programmata per martedì 3 dicembre alle 14:35 ET.
Le parti interessate possono accedere al webcast tramite la sezione 'Eventi e Presentazioni' sul sito web delle relazioni con gli investitori dell'azienda all'indirizzo investors.dynavax.com/events-presentations.
Dynavax Technologies (Nasdaq: DVAX), una empresa biofarmacéutica en etapa comercial centrada en el desarrollo de vacunas innovadoras, ha anunciado su próxima participación en la 7ª Conferencia Anual Evercore HealthCONx. La presentación está programada para el martes 3 de diciembre a las 2:35 p.m. ET.
Las partes interesadas pueden acceder a la transmisión web a través de la sección 'Eventos y Presentaciones' en el sitio web de relaciones con inversores de la empresa en investors.dynavax.com/events-presentations.
다이나백스 테크놀로지스 (Nasdaq: DVAX)는 혁신적인 백신 개발에 중점을 둔 상업 단계의 생명 공학 회사로, 제7회 에버코어 헬스컨퍼런스에 참여할 예정임을 발표했습니다. 발표는 12월 3일 화요일 오후 2시 35분(ET)으로 예정되어 있습니다.
관심 있는 분들은 회사의 투자자 관계 웹사이트의 '이벤트 및 발표' 섹션을 통해 웹 캐스트에 접근할 수 있습니다. 주소는 investors.dynavax.com/events-presentations입니다.
Dynavax Technologies (Nasdaq: DVAX), une entreprise biopharmaceutique en phase commerciale spécialisée dans le développement de vaccins innovants, a annoncé sa prochaine participation à la 7ème Conférence Annuelle Evercore HealthCONx. La présentation est prévue pour le mardi 3 décembre à 14h35 ET.
Les parties intéressées peuvent accéder au webinaire via la section 'Événements et Présentations' sur le site de relations avec les investisseurs de la société à l'adresse investors.dynavax.com/events-presentations.
Dynavax Technologies (Nasdaq: DVAX), ein biopharmazeutisches Unternehmen in der kommerziellen Phase, das sich auf die Entwicklung innovativer Impfstoffe konzentriert, hat seine bevorstehende Teilnahme an der 7. Jahreskonferenz Evercore HealthCONx angekündigt. Die Präsentation ist für Dienstag, den 3. Dezember, um 14:35 Uhr ET geplant.
Interessierte Parteien können über den Bereich 'Veranstaltungen & Präsentationen' auf der Website der Investorenbeziehungen des Unternehmens auf den Webcast zugreifen unter investors.dynavax.com/events-presentations.
- None.
- None.
The presentation will be webcast and may be accessed through the "Events & Presentations" page on the "Investors" section of the Company's website at https://investors.dynavax.com/events-presentations.
About Dynavax
Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis B Vaccine (Recombinant), Adjuvanted], which is approved in the
For Investors/Media:
Paul Cox
pcox@dynavax.com
510-665-0499
Nicole Arndt
narndt@dynavax.com
510-665-7264
View original content to download multimedia:https://www.prnewswire.com/news-releases/dynavax-to-present-at-the-7th-annual-evercore-healthconx-conference-302315117.html
SOURCE Dynavax Technologies
FAQ
When is Dynavax (DVAX) presenting at the Evercore HealthCONx Conference?
How can I watch Dynavax's (DVAX) Evercore HealthCONx Conference presentation?
What type of company is Dynavax (DVAX)?
